BAY94-8862-17530 (Finerenone) - FIGARO

Investigator: Mahendra Jain, MD

Study Coordinator: Bela Jain

Status: Enrolling

ClinicalTrials.gov Number: NCT02545049

Phone: 281.485.3434

IRB Number: Pro00013345

Description

The purpose of this study is to evaluate whether oral finerenone (study drug), in addition to standard daily therapy, is effective and safe in treating patients with type 2 diabetes mellitus and diabetic kidney disease, when compared to a placebo.
More to Explore